tradmap

NEO Earnings Neogenomics Inc

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$0 $0 $0 2012 2012 2013 2013 2013 2014 2014 2014 2014 2015
EPS
Revenue (annual)
$0 $364M $727M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$144M -$68M $8M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$0 -$0 $0 Q1 '13 Q1 '15 Q2 '15 Q3 '15 Q1 '16 Q2 '16 Q3 '16
EPS
Revenue (quarterly)
$0 $95M $190M Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25
Revenue
Net income (quarterly)
-$45M -$23M $0 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25
Net income

Reported EPS history

1–23 of 23
Q3 20162016-09-30-0.212016-11-0710-Q
Q2 20162016-06-30-0.142016-08-0510-Q
Q1 20162016-03-31-0.072016-05-1010-Q
FY 20152015-12-31-0.042016-04-1810-K
Q3 20162015-09-30-0.022016-11-0710-Q
Q2 20162015-06-30-0.022016-08-0510-Q
Q1 20162015-03-31-0.012016-05-1010-Q
FY 20152014-12-310.022016-04-1810-K
FY 20152014-09-30-0.012016-04-1810-K
FY 20152014-06-300.012016-04-1810-K
FY 20152014-03-310.002016-04-1810-K
FY 20152013-12-310.042016-04-1810-K
FY 20132013-09-300.022014-02-2410-K
FY 20132013-06-300.012014-02-2410-K
Q1 20142013-03-310.002014-05-1210-Q
FY 20142012-12-310.002015-03-0310-K
FY 20132012-09-30-0.022014-02-2410-K
FY 20132012-06-300.012014-02-2410-K
FY 20132012-03-310.012014-02-2410-K
FY 20132011-12-31-0.032014-02-2410-K
FY 20132011-09-300.002014-02-2410-K
FY 20132011-06-30-0.012014-02-2410-K
FY 20132011-03-31-0.022014-02-2410-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.